Address
Zephyr AI Inc
Parkland Hall At Old Parkland
3889 Maple Avenue, Suite 500
Dallas, TX 75219
United States
Zephyr AI Inc
1800 Tysons Blvd, Suite 901
Mclean, VA 22102
United States
VCID: 7713555
Profile
Corporate information
Official name
Zephyr AI Inc
Registration country
Official identities
US CIK 0001915384
Official identities
Company type
Precision medicine startup.Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. Through partnerships and proprietary data, Zephyr AI is curating the world’s most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support patients and providers and fuel ongoing research. At Zephyr AI, our mission-focused team of world-class software engineers and biologists leverage big data and next-generation technology to derive transformational insights and build enduring partnerships that will revolutionize the treatment of cancer and cardiometabolic disease.
Funding
Funding rounds
Series A USD 111,000,000
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Eli Lilly & Co | Initial investment. Round participant. | |||
EPIQ Capital Group LLC | Multi-family office and investment firm. | Initial investment. Round participant. | ||
Jeffrey Skoll | Initial investment. Round participant. | |||
Revolution Management Co LLC | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
Investor | Round | |
---|---|---|
Eli Lilly & Co |
Series A | |
EPIQ Capital Group LLC Multi-family office and investment firm. |
Series A | |
Jeffrey Skoll |
Series A | |
Revolution Management Co LLC |
Series A |